Last reviewed · How we verify
Conventional Care Regimen
Conventional Care Regimen is a standard-of-care treatment protocol rather than a single drug, typically consisting of established therapeutic agents used as a comparator arm in clinical trials.
At a glance
| Generic name | Conventional Care Regimen |
|---|---|
| Sponsor | Celgene |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a control or comparator arm in Phase 3 trials, Conventional Care Regimen represents the existing standard treatment approach for a given indication. It serves as the baseline against which investigational therapies are evaluated. The specific composition varies by trial and therapeutic area but generally includes approved, established medications known to be effective for the condition being studied.
Approved indications
Common side effects
Key clinical trials
- Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS (NA)
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma (PHASE3)
- Effectiveness of Stanley Paris Manual Therapy vs. Conventional Physiotherapy in Reducing Pain and Improving Function in Grade II Knee Osteoarthritis (NA)
- Postoperative Analgesia and Ventilation After Cardiac Surgery
- A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) (PHASE3)
- Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies (PHASE3)
- Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis (PHASE2)
- Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |